At the American College of Emergency Physicians (ACEP) annual meeting in Chicago, October 27-30, 2014, Mindray announces the new M9 premium compact ultrasound system, the next generation in point-of-care ultrasound technology.
A powerful, versatile, and mobile system, the M9 is designed to provide physicians fast, superior quality imaging for immediate clinical management and decision-making.
The introduction of point-of-care ultrasound into the frontline of emergency and critical care medicine has a significant impact by bringing the service to the patient. The M9 is intuitive and easy to use.
It also offers expanded flexibility, including broad general imaging and comprehensive cardiac applications appropriate for the fast-paced and demanding emergency department environment. Backed by advanced signal processing and newly designed adaptive algorithms, the M9 incorporates power, smarts and simplicity, allowing both novice and experienced clinicians to make decisions with confidence.
Additionally, the M9’s single crystal transducer with 3T technology provides deeper penetration and sharper image quality, giving physicians confidence.
This unique technology also supports the M9’s significantly improved cardiac tissue tracking accuracy and effectiveness for real-time quantitative assessment of myocardial function. In the M9, enhanced technology is coupled with enhanced mobility; there is a 7-second start-up from standby and greater than 3 hours of battery life, all within a slim profile ergonomic cart.
"Mindray is already a leader in point-of-care ultrasound solutions, but the introduction of the M9 responds to the demands of physicians at the most challenging points, in the emergency department and critical care," said George Solomon, President of Mindray North America. "The integrated package with its premium image quality has received very positive feedback from physicians, as it helps ensure diagnostic confidence while also containing costs."
Mindray is a developer, manufacturer, and supplier of medical devices in three established business segments: Patient Monitoring and Life Support, Medical Imaging Systems, and In-Vitro Diagnostic Products.